The San Francisco Bay Area is the birthplace of modern biotech, and it runs neck and neck with Cambridge, MA, as the world's pre-eminent life sciences hub. Much of the Bay Area's activity has taken place outside San Francisco itself, but now the city is becoming part of the fabric as the Mission Bay neighborhood transforms into the next great urban biotech core.
On December 17, we're gathering to discuss how the Bay Area, from Mission Bay to Berkeley to Silicon Valley, will provide unique biotech leadership in the 21st century. It's the home of biomedical history and hallowed institutions, and it's also teeming with anti-establishment ideas. Its entrepreneurs are turning cutting-edge science into companies to treat and cure diseases, and they're also turning to new digital technologies to remake healthcare (and perhaps prevent disease in the first place).
Join us to shake things up with an afternoon of fast-paced discussion, debate, and science in Mission Bay, the Bay Area's new biotech epicenter.
Regis Kelly, Director, QB3
Sam Hawgood, Chancellor, University of California, San Francisco
C. Randal Mills, President and CEO, California Institute for Regenerative Medicine
Mark Goldsmith, Partner, Third Rock Ventures
Gini Deshpande, CEO, NuMedii
Lindy Fishburne, Executive Director, Breakout Labs; SVP for Investments, Thiel Foundation
Dongliang Ge, Director of Bioinformatics, Gilead Sciences
Arvind Gupta, Investment Partner, SOSventures; Co-founder, IndieBio Accelerator
Chris Haskell, Head of U.S. Science Hub, Bayer HealthCare
Robert C. Jones, EVP of Research & Development, Fluidigm
Ted Love, CEO, Global Blood Therapeutics
Stephanie Marrus, Director of the Entrepreneurship Center, University of California, San Francisco
Rick Morrison, CEO, Comprehend Systems
Jack Newman, Co-founder and CSO, Amyris
David Shaywitz, CMO, DNAnexus
Registration: 1:00 - 2:00 pm
Program: 2:00 - 5:30 pm
Networking Reception: 5:30 - 6:30 pm
View full agenda
Tickets are transferable but not refundable.
To inquire about press registration, email firstname.lastname@example.org.
Alexandria Real Estate Equities
Halloran Consulting Group • Johnson & Johnson Innovation
Kilpatrick Townsend • Latham & Watkins
Rice University • SRI International
Texas Medical Center
VENTURE CAPITAL MEMBERS
Avalon Ventures • ARCH Venture Partners
Polaris Partners • Psilos
Sante Ventures • SR One
Third Rock Ventures
LIFE SCIENCES MEMBERS
Acorda Therapeutics • Alnylam Pharmaceuticals
Epizyme • Genocea Biosciences
Health Advances • NPS Pharmaceuticals
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, Indiana, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.